Macular lesions during systemic therapy with depot tetracosactrin.
D000324:Adrenocorticotropic Hormone / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D005128:Eye Diseases / Q000139:chemically induced; D006801:Humans; D008266:Macula Lutea; D008297:Male; D008875:Middle Aged; D012162:Retinal Degeneration / Q000139:chemically induced; D014786:Vision Disorders / Q000209:etiology
D000324:Adrenocorticotropic Hormone